The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
July 4th 2025
Stroke, myocardial infarction, and all-cause death were included in the composite of adverse cardiovascular events.
Specialty Drug Pipeline Poised to Offer Many New Therapies in the Coming Year
September 21st 2020There were a number of FDA approvals in 2019 that were either the first new therapies or first in class approved for certain conditions, and the specialty pipeline is continuing to grow at a rapid pace.
Read More
Scientists Predict COVID-19 to Become Seasonal Virus in Near Future
September 18th 2020The new study suggests that COVID-19 will follow the track of other respiratory viruses and become seasonal in countries with temperate climates, but only when herd immunity is attained through natural infection or vaccinations.
Read More
Antidepressant Discontinuation: What the Tertiary Databases and Package Insert Tells You
September 16th 2020Discontinuation of antidepressants should take place gradually, as abrupt stoppage or marked reduction in the dosage of an antidepressant is frequently associated with adverse effects (AEs), such as withdrawal symptoms.
Read More
Managing Prescribing Rules, Implementing Real Time Verifications into Workflow During COVID-19
September 16th 2020The growth of telehealth, ongoing prescriber verification challenges, and the need for a universal patient identifier are all key issues that have arisen for pharmacists during the COVID-19 pandemic.
Read More
FDA Approves Fluticasone Furoate, Umeclidinium, Vilanterol for Treatment of Asthma
September 14th 2020The triple combination therapy is the first single inhaler triple therapy approved for both asthma and COPD and is the only single inhaler triple therapy available as a once-daily inhalation.
Read More
Coordinated Approach Needed to Increase Follow-Up Care After Rapid HIV, HCV Testing
September 14th 2020Successfully implementing HIV and hepatitis C testing at drug detoxification centers could help identify and link patients to care, but would require that the test results are available to nearby health care facilities.
Read More